Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Luigi Naldi

Showing results (21-30 of 289) with videos related to

Pageof 29
Sort By:
Dermatology (Basel, Switzerland)|April 7, 2016
Author's Reply to the Response to the Commentary of Naldi and Cazzaniga Entitled 'Are All Screening Programmes Created Equal? The Case of Melanoma'Luigi Naldi, Simone Cazzaniga
Clinical Evidence|September 2, 2005
Chronic plaque psoriasisLuigi Naldi, Berthold Rzany
Expert Review of Clinical Immunology|November 2, 2018
The relationship between smoking, psoriasis and psoriatic arthritisElena Pezzolo, Luigi Naldi
The Journal of Investigative Dermatology|June 17, 2006
Assessing the impact of psoriasis and the relevance of qualitative researchRay Jobling, Luigi Naldi
Dermatologic Clinics|March 4, 2009
Registry research in dermatologyLuigi Naldi, Liliane Chatenoud
The New England Journal of Medicine|January 24, 2009
Clinical practice. Seborrheic dermatitisLuigi Naldi, Alfredo Rebora
Dermatology (Basel, Switzerland)|September 26, 2015
Are All Screening Programmes Created Equal? The Case of MelanomaLuigi Naldi, Simone Cazzaniga
Expert Review of Clinical Immunology|January 22, 2020
Epidemiology of major chronic inflammatory immune-related skin diseases in 2019Elena Pezzolo, Luigi Naldi
The Journal of Investigative Dermatology|August 18, 2020
Research Techniques Made Simple: Latent Class AnalysisLuigi Naldi, Simone Cazzaniga
JAMA Dermatology|May 31, 2023
Biosimilars for the Treatment of Psoriasis-A Systematic Review of Clinical Trials and Observational Studies: Looking Beyond Single-Trial Evidence for a Valuable ChoiceLuigi Naldi, Antonio Addis
Pageof 29

Showing results (21-30 of 289) with videos related to

Sort By:
Pageof 29
Dermatology (Basel, Switzerland)|April 7, 2016
Author's Reply to the Response to the Commentary of Naldi and Cazzaniga Entitled 'Are All Screening Programmes Created Equal? The Case of Melanoma'Luigi Naldi, Simone Cazzaniga
Clinical Evidence|September 2, 2005
Chronic plaque psoriasisLuigi Naldi, Berthold Rzany
Expert Review of Clinical Immunology|November 2, 2018
The relationship between smoking, psoriasis and psoriatic arthritisElena Pezzolo, Luigi Naldi
The Journal of Investigative Dermatology|June 17, 2006
Assessing the impact of psoriasis and the relevance of qualitative researchRay Jobling, Luigi Naldi
Dermatologic Clinics|March 4, 2009
Registry research in dermatologyLuigi Naldi, Liliane Chatenoud
The New England Journal of Medicine|January 24, 2009
Clinical practice. Seborrheic dermatitisLuigi Naldi, Alfredo Rebora
Dermatology (Basel, Switzerland)|September 26, 2015
Are All Screening Programmes Created Equal? The Case of MelanomaLuigi Naldi, Simone Cazzaniga
Expert Review of Clinical Immunology|January 22, 2020
Epidemiology of major chronic inflammatory immune-related skin diseases in 2019Elena Pezzolo, Luigi Naldi
The Journal of Investigative Dermatology|August 18, 2020
Research Techniques Made Simple: Latent Class AnalysisLuigi Naldi, Simone Cazzaniga
JAMA Dermatology|May 31, 2023
Biosimilars for the Treatment of Psoriasis-A Systematic Review of Clinical Trials and Observational Studies: Looking Beyond Single-Trial Evidence for a Valuable ChoiceLuigi Naldi, Antonio Addis
Pageof 29